Tag: Prescription Drugs
Mortality Up With Loss of Low-Income Subsidy for Drugs
Mortality difference amplified for users of medications for cardiovascular disease, chronic lung disease, HIV
Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis
Risk for postoperative eKA slightly increased; lower risks seen for perioperative acute kidney injury and 30-day mortality
Ubrogepant During Prodromal Phase of Migraine Eases Symptoms
Ubrogepant may treat prodromal symptoms, including photophobia, fatigue, phonophobia, cognitive dysfunction from as early as one hour
RSV Vaccines, Nirsevimab Tied to Reduced RSV-Linked Hospitalization
Reduction in 2024-2025 RSV-associated hospitalization rates seen among infants aged 0 to 7 months with maternal vaccination or nirsevimab
Mepolizumab Yields Lower Rate of Moderate/Severe Exacerbations in COPD
Time to first moderate or severe exacerbation longer with mepolizumab in patients with COPD, history of exacerbations, eosinophil count ≥300 cells/µL
Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer
Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors
Intraocular Inflammation More Common With Aflibercept Injections in Real-World Setting
Findings seen for patients being treated for neovascular age-related macular degeneration or diabetic macular edema
Guidelines Updated for Nonoccupational Postexposure Prophylaxis for HIV
Regimens can be tailored to clinical circumstances, and medical follow-up should also be tailored
Changing Trends Seen in Psychotherapy in Outpatient Mental Health Care
Role of psychotherapy increasing in mental health care, while use of psychotropic meds without psychotherapy decreasing
Asthma Attacks Increase for Some Women Taking Progestogen-Only Pill
Increased risk for attacks seen in women younger than 35 years, those with eosinophilia, those with lower corticosteroid use
